Profiling phospholipid elution in reversed-phase LC-MS/MS bioanalytical methods in order to avoid matrix effects

Steve Silvester1, Luke Smith

  • 1Department of Clinical Pharmacology & DMPK, AstraZeneca R&D, Charnwood, Bakewell Road, Loughborough, LE11 5RH, UK. stephen.silvester@astrazeneca.com

Bioanalysis
|April 27, 2012
PubMed
Abstract